Article
Effect of the UGT2B15 genotype on the pharmacokinetics, pharmacodynamics, and drug interactions of intravenous lorazepam in healthy volunteers.
Clinical pharmacology and therapeutics - 1 Jun 2005
Chung Jae-Yong, Cho Joo-Youn, Yu Kyung-Sang, Kim Jung-Ryul, Jung Hye-Ryung, Lim Kyoung-Soo, Jang In-Jin, Shin Sang-Goo
Abstract excerpt
OBJECTIVE: Our objective was to investigate the effect of the uridine 5'-diphosphate-glucuronosyltransferase (UGT) 2B15 genetic polymorphism on the pharmacokinetics and pharmacodynamics of lorazepam in basal, inhibited, and induced metabolic states in healthy normal volunteers. METHODS: Twenty-four healthy subjects were enrolled and grouped into UGT2B15*1/*1 or UGT2B15*2/*2 genotype groups. The pharmacokinetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
